PropertyValue
?:abstract
  • INTRODUCTION: There is considerable overlap between the clinical manifestations of covid-19 pneumonia and the acute interstitial lung disease seen in certain rheumatic disorders. In addition, pulmonary fibrosis is increasingly recognised as a potentially serious consequence of both. METHODS: This review explores this overlap of clinical features, risk factors and causation, offering insights into the immune mechanisms that contribute to both sets of disorders. RESULTS: The therapeutic role of immunosuppression and biologic agents in the treatment of covid-19 is explained in the light of this. DISCUSSION: We propose how lessons learned from the insights recently gained into each disorder can improve our insight into immunological mechanisms and application of therapeutic interventions in the other.
?:creator
?:doi
?:doi
  • 10.1007/s11845-021-02545-y
?:journal
  • Ir_J_Med_Sci
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/a8b4abda8e065cb179a6f61c04dc19dbfb723bfe.json
?:pmcid
?:pmid
?:pmid
  • 33564974.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • There are similarities between rheumatic disease with lung involvement and COVID-19 pneumonia
?:type
?:year
  • 2021-02-10

Metadata

Anon_0  
expand all